CME vs. RKT: CME vs. Rocket Stock Comparison

Company Profile

CME (CME) and Rocket (RKT) both fall under the Financial Services industry group, but CME is classified in Capital Markets while RKT is classified in Financial Services.

CME (CME) has more than two decades of public-market history since December 6, 2002, whereas Rocket (RKT) listed on August 6, 2020 and has a much shorter record to draw on.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Rocket (RKT) has a highly aggressive beta of 2.19, indicating much higher sensitivity to broad-market moves, while CME (CME) is defensive at 0.16 and tends to be less market-sensitive — a wide gap in beta profiles.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both CME (CME) at 16.13% and Rocket (RKT) at 7.86% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

CME (CME) at 63.48% converts revenue to bottom-line profit above its industry’s benchmark range, while Rocket (RKT) at 11.02% keeps roughly the typical share for its industry.

CME (CME) at 65.85% operates in the top operating margin quartile, ahead of Rocket (RKT) at 43.54%, which runs around its industry’s norm.

Profitability Metrics

Growth

Rocket (RKT) at 26.87% sits in the top revenue growth quartile, while CME (CME) at 6.37% is closer to the peer norm — faster top-line expansion for RKT.

CME (CME) at 15.41% is around its peer norm for EPS growth, while Rocket (RKT) at -123.81% drops into the bottom quartile, signaling weaker earnings momentum.

Growth Metrics

Financial Strength

current ratio doesn’t apply on either side: CME (CME) in Financial Services and Rocket (RKT) in Financial Services both report balance sheets without a current/non-current split, so their short-term liquidity is better judged through regulatory and funding measures.

debt-to-equity ratio is set aside for both: CME (CME) in Financial Services and Rocket (RKT) in Financial Services run businesses where balance-sheet leverage is part of the model, so capital-adequacy and funding measures are the better gauges of balance-sheet risk.

Financial Strength Metrics

Dividends

Rocket (RKT) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CME (CME) reports a yield of 1.68%, ranking against industry peers normally.

Rocket (RKT) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile CME (CME) reports a payout of 92.62%, ranking against industry peers normally.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: CME (CME) trades at 25.07 times trailing earnings, ranked against its peers, while Rocket (RKT) has no P/E ratio this period.

Rocket (RKT) at 3.61 prices around its industry’s typical P/S ratio, while CME (CME) at 15.74 clears its benchmark range — CME looks notably rich on sales.

Rocket (RKT) at 1.76 is valued about in line with its industry on P/B ratio, while CME (CME) at 4.12 carries an above-peer premium to book — CME is pricier on assets.

Valuation Metrics